East-Mab Biomedical

East-Mab Biomedical is a China-based biotechnology company focused on recombinant protein raw materials for biopharma, diagnostics, and advanced cell culture applications. Founded in 2016, the company appears to have transitioned from antibody drug R&D into a commercial supplier of GMP-grade cell culture proteins, IVD diagnostic proteins, medical and diagnostic enzymes, and custom protein/antibody services. Its technology stack includes CHO, HEK293, Escherichia coli, and yeast expression systems, along with protein engineering, purification, formulation, and application platforms. East-Mab serves customers in IVD, cell therapy, organoid culture, stem cell culture, and related industrial biotech markets, and highlights FDA DMF filings, ISO certifications, and GMP-conformant production capabilities. The company operates major R&D and manufacturing sites in Nantong and Suzhou, China, and markets globally under the EastMabBio brand.